The New Emphasis of Lipoprotein Particles for Cardiovascular Risk Assessment

Presented by: Dr. Jan Troup



  • Addressing the new emphasis of lipoprotein particles over cholesterol for lipid management
  • ATP IV has been cancelled: Particles are in and cholesterol is out
  • Review the enhancements of the LPP™ technology
  • Interpreting new information available from the LPP™ assay
  • Learn how lipoprotein subgroup measurement provides better risk assessment and therapeutic approach

Watch Now - Watch Now Button